Scientists from IBEC and UPC discover super-stretchy cells Blog Post

In a study published today in Nature, researchers from the Institute for Bioengineering of Catalonia (IBEC) at PCB and the Universitat Politècnica de Catalunya (UPC) report a new physical property of cells  that may explain the unusual ability of cells to undergo extreme deformations without breaking. The research could help us build better artificial organs or new bionic technologies such as organs-on-a-chip.

 

Cebiotex awarded the Cecot Recognition of Innovation prize 2018 Blog Post

Cebiotex– the first spin-off between the SJD Barcelona Children’s Hospital (HSJD) and the Universidad Politécnica de Catalunya (UPC)– awarded the Cecot Recognition of Innovation prize 2018. Joan Bertran, CEO and co-founder of the biotechnology company based at the Barcelona Science Park (Parc Científic de Barcelona, PCB), yesterday received the award at the Cecot Recognition of Business Progress prize-giving ceremony at the National Theatre of Catalonia, as part of the 24th Night of the Entrepreneur, which was chaired by the president of Catalonia, Quim Torra.

 

The UTOX-PCB Unit renews and extends its certificate of compliance with Good Laboratory Practices Blog Post

The Unit of Experimental Toxicology and Ecotoxicology of the Barcelona Science Park has renewed its certificate of compliance with Good Laboratory Practices (GLP) for the conduct of all types of in vivo and in vitro toxicology studies, mutagenicity studies and ecotoxicity studies involving medicinal products for human and veterinary use, medical devices and cosmetics. The site has also extended the certification for microbiological studies of bactericide efficiency. 

 

Researchers from CNAG-CRG and IDIBAPS receive a €8.3 million ERC Synergy Grant Blog Post

The European Research Council (ERC) today announced the results of the 2018 ERC Synergy Grants Call. A project, the BCLL@las, of four research groups from the Centro Nacional de Análisis Genómico (CNAG-CRG) –based in the Barcelona Science Park and integrated into the Centre for Genomic Regulation (CRG)– and the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) have received this prestigious grant to unravel the genomics and epigenomics of chronic lymphocytic leukemia – the most frequent adult leukemia in the Western world– at unprecedented resolution using single-cell analysis. 

 

AELIX Therapeutics and Gilead Sciences enter into a clinical research collaboration agreement for HIV Cure Blog Post

AELIX Therapeutics, a clinical-stage biotechnology company based in the Barcelona Science Park and specialized in the discovery and development of immunotherapies for HIV infection, announces that it has entered into a clinical research collaboration with Gilead Sciences, a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Both companies will jointly evaluatejointly evaluate proprietary investigational products in a strategic clinical study aimed at achieving a functional cure of HIV infection.

 

Bionure appoints Dr. Laurent Nguyen as CEO Blog Post

Bionure Farma, a biotech company specialized in neuroprotection, today announces the appointment of Dr. Laurent Nguyen as the new Chief Executive Officer of the company and names Dr. Amit Bar-Or as member of its Scientific Advisory Board (SAB) led by Dr. Pablo Villoslada, the scientific founder of the company.

 

Researchers from IBMB-CSIC decipher the first level of DNA folding Blog Post

DNA topology team from the Structural Biology Unit (SBU) of the Institute of Molecular Biology of Barcelona (IBMB-CSIC) at  the Barcelona Science Park has solved the so-called “paradox of the nucleosomal DNA linking number”. They have been able to show that the theory described about how DNA is packaged in our cells was true. The solution to this problem, which has been the subject of debate for more than 3 decades, has been published in the journal Nature Communications.